Zobrazeno 1 - 10
of 131
pro vyhledávání: '"H. Schwinn"'
Autor:
D, Josić, L, Hoffer, A, Buchacher, H, Schwinn, W, Frenzel, L, Biesert, H P, Klöcking, P, Hellstern, R, Rokicka-Milewska, A, Klukowska
Publikováno v:
Thrombosis Research. 100:433-441
The paper describes the production of a prothrombin complex concentrate (PCC) with high virus safety and a well-balanced content of vitamin K-dependent clotting factors and inhibitors. Solid-phase extraction is followed in a second step by optimized
Publikováno v:
Hämostaseologie. 15:49-53
ZusammenfassungOctavi SDPIus ist ein hochgereinigtes, doppelt virusinaktiviertes Faktor-Vll I-Konzentrat. Die spezifische Aktivität beträgt im Endprodukt mehr als 100 IU/mg Gesamtprotein. Die Stabilisierung des Faktor VIII erfolgt durch Bindung an
Publikováno v:
Beton- und Stahlbetonbau. 98
Autor:
E L, Saenko, N, Ananyeva, D, Kouiavskaia, H, Schwinn, D, Josic, M, Shima, C A E, Hauser, S, Pipe
Publikováno v:
Vox sanguinis. 83(2)
Molecular defects in Factor VIII (FVIII), such as haemophilia A-related mutations or denaturative conformational changes, may affect the stability of FVIII as well as its interactions with physiological activators, von Willebrand Factor, phospholipid
Publikováno v:
Journal of chromatography. A. 852(1)
The surface plasmon resonance phenomenon is used for real time measurements of protein-protein and protein-membrane interactions. In the present study two surface plasmon resonance-based binding assays permitting study of the interaction of coagulati
Publikováno v:
Journal of chromatography. B, Biomedical sciences and applications. 715(1)
The region of von Willebrand factor, which is involved in the complex formation with factor VIII, was used to generate a panel of octapeptides. A peptide ladder was generated from the von Willebrand factor region aa40 to aa100 and was synthesized on
Publikováno v:
Arzneimittel-Forschung. 44(2)
In an assessment of the risks of virus transmission by clotting concentrates it is clear that the currently practised procedures for virus inactivation are not equally effective against all types of viruses; neither a pasteurisation nor the solvent d
In an assessment of the risks of virus transmission by clotting concentrates it is clear that the currently practised procedures for virus inactivation are not equally effective against all types of viruses ; neither a pasteurisation nor the solvent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::02325cbad49f50684a592dca3487089c
https://www.bib.irb.hr/990317
https://www.bib.irb.hr/990317
Autor:
H. Schwinn
Publikováno v:
Neue Entwicklungen in der Transfusionsmedizin ISBN: 9783540553625
Die Behandlung von Plasmaderivaten mit Tributylphosphat (TNBP) und Detergentien zum Zwecke der Virusinaktivierung hat sich in den 6 Jahren seit ihrer Einfuhrung bewahrt und findet zunehmend breitere Anwendung.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcf0d84c78a3cef29818d8d8259e25e3
https://doi.org/10.1007/978-3-642-77443-0_4
https://doi.org/10.1007/978-3-642-77443-0_4
Publikováno v:
Transfusion Clinique et Biologique. 5:82s-83s